Skip to main content

This Is The Most Marijuana-Friendly Congress In History

One of President Donald Trump’s favorite Fox News Channel personalities is joining the board of a CBD company.

Jeanine Pirro, host of “Justice with Judge Jeanine,” will sit on the board of directors of HeavenlyRx, effective immediately, the firm said in a press release on Wednesday. The company is a subsidiary of SOL Global Investments Corp., which holds stakes in a variety of cannabis-related businesses.

“My interest in CBD stems from a curiosity after hearing people say how much they benefited from CBD,” Pirro, who previously served as a New York district attorney, told Marijuana Moment in response to emailed questions. “I am now excited to be a part of the opportunity for people to access fantastic wellness options that are both natural and physically and emotionally beneficial.”

“Initially a skeptic, I now understand there are tremendous benefits outside the assembly line of traditional medical and pharmaceutical dictates,” she said.

If Pirro chooses to amplify the CBD brand on her weekend show or social media accounts, it’s reasonable to assume that at least one influential fan will be tuned in: The president of the United States. Trump tweeted segments of Pirro’s show twice within the last week alone and frequently promotes her favorable coverage of his administration.

“Jeanine clearly has a long and impressive track record of being a powerful advocate for the causes she believes in,” HeavenlyRx CEO Paul Norman, formerly the president of Kellogg Company North America, told Marijuana Moment. “That was evident during her career as [a district attorney] and now as a champion of the people.”

“Her research into hemp and CBD and its benefits over the last months gave us a clear vision into why she became such a phenomenal success as a judge, journalist and TV personality,” he said. “We are simply thrilled to have her as a partner on the HeavenlyRx team.”

The announcement that Pirro is joining the company’s board comes four months after the host’s show was suspended by Fox News, a move that reportedly stemmed from her suggestion that the Muslim faith of Rep. Ilhan Omar (D-MN) was “antithetical” to the U.S. Constitution. Fox subsequently condemned the remarks, but her show was reinstated about two weeks after the controversy.

While hemp and its derivatives were legalized under the 2018 Farm Bill that Trump signed into law late last year, don’t expect Pirro to be making the case for ending cannabis prohibition more broadly any time soon. HeavenlyRx explicitly does not associate with products containing THC, and the Fox News host has indicated that her support for reform is limited to legalizing medical cannabis.

That said, given her closeness to the White House and her massive media platform, Pirro is positioned to expand the mainstream appeal of hemp-derived CBD and contribute to the industry’s ongoing growth.

Top Senate Democrat Cuts Ribbon On New Hemp Facility

Photo elements courtesy of Gage Skidmore and Kimzy Nanney.

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.

Original Article Source: https://www.marijuanamoment.net/this-is-the-most-marijuana-friendly-congress-in-history/

Comments

Post a Comment

Popular posts from this blog

Could CBD Lead To The Development Of Safer Antipsychotic Medications?

Antipsychotic medications are important for managing a number of different psychiatric ailments, including bipolar disorders, schizophrenia, and even dementia. These drugs can greatly improve the manageability of symptoms that often distort one’s experience of reality. They can also create major mood disruptions and lead to a number of behavioral and emotional difficulties. Antipsychotic and anti-psychosis medications can be life-changing for people with such disorders, enabling them to live more normal and manageable lives without their symptoms taking over. These drugs work by regulating neurotransmitters in the brain so that naturally occurring imbalances and dysfunctions no longer disrupt mental and emotional processes. Often, reaching this outcome is much easier said than done; it can take a lot of time to find courses and combinations of treatments that work. It’s sometimes necessary to make adjustments to find the right balance for the individual and it’s not unusual for outc...
Post a Comment
Read more

Can Medical Marijuana Help Aging Parents With Dementia?

For decades, marijuana, even for medical uses, was demonized or questioned.  When states like Colorado legalized it for recreational use, more studies began to determine provable efficacy for its use as a medicine. The Federal government still classifies marijuana the same way it classifies heroin: harmful and with no medical benefits. Now we can see that this is wrong. When states legalized marijuana, referred to as cannabis here, they had an interest in getting data to see what good it could do. Proving efficacy could increase medical marijuana sales, benefit people who might at least find some medical use, and overall would bring tax dollars into the state coffers. Without funding studies, the Federal government has done very little to demonstrate what good cannabis can do. After all, if the presumption is that it helps nothing, there would be no motivation to determine with scientific data that it does anyone any good. But we have convincing data now about its beneficial use ...
Post a Comment
Read more

Cannabis Watch: Canopy Growth To Book Charge Of Up To $568 Million As Marijuana Restructuring Continues

Canopy Growth Corp. said early Thursday it was halting a range of operations across three continents and expects its restructuring plans to result in a charge of up to C$800 million (567.9 million) in the fiscal fourth quarter. U.S.-traded shares US:CGC CA:WEED of the cannabis company fell 1.9% in afternoon trading. Canopy said it was selling operations in Africa, curtailing cultivation of hemp in the U.S. and Columbia, and shutting down an indoor production facility in Canada. The announcement will result in 85 job cuts, the company said. “When I arrived at Canopy Growth in January, I committed to conducting a strategic review in order to lower our cost structure and reduce our cash burn,” Canopy Chief Executive David Klein said in a statement. Read: As cannabis industry stays largely quiet on coronavirus, this CEO has been sounding the alarm Canopy’s restructuring announcement was expected by investors, Cowen analyst Vivien Azer wrote in a note to clients Thursday. Azer rate...
Post a Comment
Read more